Adam Torres and Robert Schultz discuss Sollievo Pharmaceutical’s new treatment.

Subscribe: iTunes / Spotify / Stitcher / RSS

Apply to be a guest on our podcast here

Show Notes:

In this episode,  Adam Torres and Robert Schultz, Founder and CEO of Sollievo Pharmaceuticals, Inc., explore Sollievo Pharmaceutical’s new treatment. The company is developing a novel rapid-acting sedative to treat violent patients in the Emergency Department.

Apply to be a guest on our podcast here

Get the Mission Matters News FREE here

Share.
Adam Torres

Adam Torres is Host of the Mission Matters series of shows, ranked in the top 5% out of 3,268,702 podcasts globally. As Co-Founder of Mission Matters, a media, PR, marketing and book publishing agency, Adam is dedicated to amplifying the voices of entrepreneurs, entertainers, executives and experts. An international speaker and author of multiple books on business and investing, his advice is featured regularly in major media outlets such as Forbes, Yahoo! Finance, Fox Business, and CBS to name a few.

Please ensure Javascript is enabled for purposes of website accessibility
×

Thank You for Subscribing.